Table of Contents
International Journal of Molecular Imaging
Volume 2011 (2011), Article ID 694179, 6 pages
http://dx.doi.org/10.1155/2011/694179
Research Article

Autoradiographic Mapping of 5-HT1B/1D Binding Sites in the Rhesus Monkey Brain Using [carbonyl-11C]zolmitriptan

1Uppsala Imanet AB, GE Healthcare, P.O. Box 967, 751 09 Uppsala, Sweden
2Department of Clinical Neuroscience, Karolinska Institute, 171 77 Stockholm, Sweden
3AstraZeneca R&D, 151 85 Södertälje, Sweden
4Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Box 574, 75123 Uppsala, Sweden

Received 24 May 2011; Revised 11 August 2011; Accepted 12 August 2011

Academic Editor: Habib Zaidi

Copyright © 2011 Örjan Lindhe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Goadsby, “The pharmacology of headache,” Progress in Neurobiology, vol. 62, no. 5, pp. 509–525, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. G. R. Martin, A. D. Robertson, S. J. MacLennan et al., “Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT(1B/1D) receptor partial agonist, 311C90 (zolmitriptan),” British Journal of Pharmacology, vol. 121, no. 2, pp. 157–164, 1997. View at Google Scholar · View at Scopus
  3. P. J. Goadsby and L. Edvinsson, “Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90,” Headache, vol. 34, no. 7, pp. 394–399, 1994. View at Publisher · View at Google Scholar
  4. P. J. Goadsby and K. L. Hoskin, “Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)(1B/D) receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?” Pain, vol. 67, no. 2-3, pp. 355–359, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. P. J. Goadsby and Y. E. Knight, “Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat,” Cephalalgia, vol. 17, no. 3, pp. 153–158, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. K. J. Palmer and C. M. Spencer, “Zolmitriptan,” CNS Drugs, vol. 7, no. 6, pp. 468–479, 1997. View at Google Scholar · View at Scopus
  7. P. J. Goadsby and R. Yates, “Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy,” Headache, vol. 46, no. 1, pp. 138–149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. F. V. Caekebeke, M. D. Ferrari, C. P. Zwetsloot, J. Jansen, and P. R. Saxena, “Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks,” Neurology, vol. 42, no. 8, pp. 1522–1526, 1992. View at Google Scholar · View at Scopus
  9. I. Jansen, L. Edvinsson, A. Mortensen, and J. Olesen, “Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor,” Cephalalgia, vol. 12, no. 4, pp. 202–205, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Cumberbatch, R. G. Hill, and R. J. Hargreaves, “The effects of 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats,” European Journal of Pharmacology, vol. 362, no. 1, pp. 43–46, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. G. R. Martin, “Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine,” Cephalalgia, vol. 17, no. 18, Supplement, pp. 4–14, 1997. View at Google Scholar · View at Scopus
  12. M. Bergström, R. Yates, A. Wall, M. Kågedal, S. Syvänen, and B. Långström, “Blood-brain barrier penetration of zolmitriptan—modelling of positron emission tomography data,” Journal of Pharmacokinetics and Pharmacodynamics, vol. 33, no. 1, pp. 75–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Långström, P. E. Andren, Ö Lindhe, M. Svedberg, and H. Hall, “In vitro imaging techniques in neurodegenerative diseases,” Molecular Imaging and Biology, vol. 9, no. 4, pp. 161–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Mills and G. R. Martin, “Autoradiographic mapping of [3H]sumatriptan binding in cat brain stem and spinal cord,” European Journal of Pharmacology, vol. 280, no. 2, pp. 175–178, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Castro, J. Pascual, T. Romón, C. Del Arco, E. Del Olmo, and A. Pazos, “Differential distribution of [3H]sumatriptan binding sites (5-HT(1B), 5-HT(1D) and 5-HT(1F) receptors) in human brain: focus on brainstem and spinal cord,” Neuropharmacology, vol. 36, no. 4-5, pp. 535–542, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Varnäs, H. Hall, P. Bonaventure, and G. Sedvall, “Autoradiographic mapping of 5-HT1B and 5-HT1D receptors in the post mortem human brain using [3H]GR 125743,” Brain Research, vol. 915, no. 1, pp. 47–57, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Kihlberg, F. Karimi, and B. Långström, “[11C]carbon monoxide in selenium-mediated synthesis of 11C-carbamoyl compounds,” Journal of Organic Chemistry, vol. 67, no. 11, pp. 3687–3692, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. V. W. Pike, J. A. McCarron, S. P. Hume et al., “Preclinical development of a radioligand for studies of central 5-HT1A receptors in vivo [11C]WAY 100635,” Medicinal Chemistry Research, vol. 5, pp. 208–227, 1994. View at Google Scholar
  19. G. Paxinos, X.-F. Huang, and A. T. Toga, The Rhesus Monkey Brain in Stereotaxic Coordinates, Academic Press, New York, NY, USA, 2000.
  20. G. Engel, M. Gothert, and D. Hoyer, “Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT(1B) binding sites,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 332, no. 1, pp. 1–7, 1986. View at Google Scholar · View at Scopus
  21. M. Göthert, P. Propping, H. Bönisch, M. Brüss, and M. M. Nöthen, “Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role,” Annals of the New York Academy of Sciences, vol. 861, pp. 26–30, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Maura and M. Raiteri, “Cholinergic terminals in rat hippocampus possess 5-HT(1B) receptors mediating inhibition of acetylcholine release,” European Journal of Pharmacology, vol. 129, no. 3, pp. 333–337, 1986. View at Google Scholar · View at Scopus
  23. P. Bonaventure, P. Voorn, W. H. M. L. Luyten, M. Jurzak, A. Schotte, and J. E. Leysen, “Detailed mapping of serotonin 5-HT(1B) and 5-HT(1D) receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function,” Neuroscience, vol. 82, no. 2, pp. 469–484, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. A. T. Bruinvels, B. Landwehrmeyer, E. L. Gustafson et al., “Localization of 5-HT(1B), 5-HT(1Dα), 5-HT(1E) and 5-HT(1F) receptor messenger RNA in rodent and primate brain,” Neuropharmacology, vol. 33, no. 3-4, pp. 367–386, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Doucet, M. Pohl, C. M. Fattaccini, J. Adrien, S. El Mestikawy, and M. Hamon, “In situ hybridization evidence for the synthesis of 5-HT(1B) receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain,” Synapse, vol. 19, no. 1, pp. 18–28, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Jin, D. Oksenberg, A. Ashkenazi et al., “Characterization of the human 5-hydroxytryptamine(1B) receptor,” Journal of Biological Chemistry, vol. 267, no. 9, pp. 5735–5738, 1992. View at Google Scholar · View at Scopus
  27. L. Maroteaux, F. Saudou, N. Amlaiky, U. Boschert, J. L. Plassat, and R. Hen, “Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 7, pp. 3020–3024, 1992. View at Google Scholar · View at Scopus
  28. M. M. Voigt, D. J. Laurie, P. H. Seeburg, and A. Bach, “Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine(1B) receptor,” EMBO Journal, vol. 10, no. 13, pp. 4017–4023, 1991. View at Google Scholar · View at Scopus
  29. P. Boulenguez, R. Pinard, and L. Segu, “Subcellular localization of 5-HT(1B) binding sites in the stratum griseum superficiale of the rat superior colliculus: an electron microscopic quantitative autoradiographic study,” Synapse, vol. 24, no. 3, pp. 203–212, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. A.T. Bruinvels, J. M. Palacios, and D. Hoyer, “Autoradiographic characterization and localization of 5-HT1D compared to 5-HT1B binding sites in the rat brain,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 347, pp. 569–582, 1993. View at Google Scholar
  31. A. Pazos and J. M. Palacios, “Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors,” Brain Research, vol. 346, no. 2, pp. 205–230, 1985. View at Google Scholar · View at Scopus
  32. Y. Sari, “Serotonin1B receptors: from protein to physiological function and behavior,” Neuroscience and Biobehavioral Reviews, vol. 28, no. 6, pp. 565–582, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Sari, M. C. Miquel, M. J. Brisorgueil et al., “Cellular and subcellular localization of 5-hydroxytryptamine(1B) receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies,” Neuroscience, vol. 88, no. 3, pp. 899–915, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. U. Boschert, D. A. Amara, L. Segu, and R. Hen, “The mouse 5-hydroxytryptamine(1B) receptor is localized predominantly on axon terminals,” Neuroscience, vol. 58, no. 1, pp. 167–182, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. A. T. Bruinvels, J. M. Palacios, and D. Hoyer, “Autoradiographic characterisation and localisation of 5-HT(1D) compared to 5-HT(1B) binding sites in rat brain,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 347, no. 6, pp. 569–582, 1993. View at Google Scholar · View at Scopus
  36. K. M. A. Welch, Y. Cao, S. Aurora, G. Wiggins, and E. M. Vikingstad, “MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine,” Neurology, vol. 51, no. 5, pp. 1465–1469, 1998. View at Google Scholar · View at Scopus
  37. J. Pascual, C. del Arco, T. Romón, E. del Olmo, E. Castro, and A. Pazos, “[3H]sumatriptan-binding sites in post-mortem human brain,” Cephalalgia, vol. 16, no. 5, pp. 317–322, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Pascual, C. Del Arco, T. Romón, E. Del Olmo, and A. Pazos, “[3H]sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors,” European Journal of Pharmacology, vol. 295, no. 2-3, pp. 271–274, 1996. View at Google Scholar · View at Scopus
  39. M. E. Castro, J. Pascual, T. Romón, C. del Arco, E. del Olmo, and A. Pazos, “Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord,” Neuropharmacology, vol. 36, no. 4-5, pp. 535–542, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Gomez-Mancilla, N. R. Cutler, M. T. Leibowitz et al., “Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine,” Cephalalgia, vol. 21, no. 7, pp. 727–732, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. I. A. Cliffe, “A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT(1A) receptor PET radioligands,” Nuclear Medicine and Biology, vol. 27, no. 5, pp. 441–447, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Hall, C. Lundkvist, C. Halldin et al., “Autoradiographic localization of 5-HT(1A) receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635,” Brain Research, vol. 745, no. 1-2, pp. 96–108, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Farde, N. Ginovart, H. Ito et al., “PET characterization of [carbonyl-11C]WAY-100635 binding to 5-HT(1A) receptors in the primate brain,” Psychopharmacology, vol. 133, no. 2, pp. 196–202, 1997. View at Publisher · View at Google Scholar · View at Scopus